We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
SetPoint’s US pilot study in rheumatoid arthritis shows positive results
Image: The study showed that the bioelectronic medicine was well tolerated with no device-related adverse events through 12 weeks. Photo: Courtesy of SetPoint Medical.